Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 18 September 2023 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 15 September 2023 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)

Peab builds new greenhouse in the Gothenburg Botanical Garden

Peab has been commissioned to build a new greenhouse and visitors’ center in the Gothenburg Botanical Garden. The customer is Västra Götaland Region, Västfastigheter construction and management, and the contract is worth SEK 346 million.The Gothenburg Botanical Garden is one of West Sweden’s largest attractions with close to 600,000 visitors annually. The existing greenhouse was opened in the beginning of the 80s and now needs to be updated to meet current and future demands. Peab has therefore been commissioned to build a new greenhouse divided into sections with different climate zones

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, flagging notification, 18 September 2023 at 9:00 EESTNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation that it has crossed above the 5% disclosure limit on total holding in shares and voting rights on 14 September 2023. Following the transaction, BlackRock, Inc. owns 5.03% of Wärtsilä’s shares and voting rights, while its total holding in Wärtsilä Corporation corresponds to 5.12%. Total position of BlackRock, Inc. and its funds subject

Raisio plc: Managers´ transactions

Raisio plc Managers´ transactions 18 September 2023   MANAGERS’ TRANSACTIONS   Person subject to the notification requirement Name: Lauri Sipponen Position: Member of the Board/Deputy member Issuer: Raisio Oyj LEI: 74370083282NHIP4QD02   Notification type: INITIAL NOTIFICATION Reference number: 37909/5/4 ____________________________________________   Transaction date: 2023-09-15 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009002943 Nature of transaction: ACQUISITION   Transaction details (1): Volume: 8060

K-Fastigheter announces intention to carry out a directed issue of convertible bonds

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEELAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE, PLEASE REFER TO “DISCLAIMER” AT THE END OF THIS PRESS RELEASE. K-Fast Holding AB (publ) (”K-Fastigheter” or the ”Company”) is investigating the possibility to carry out a directed issue of convertible bonds (the ”Convertible Bonds”) of an aggregate amount of SEK 300m

DBP International AB and Vivo Biopharma LLC Enter into Asset Purchase and Collaboration agreements to Develop and Commercialize a novel Glioblastoma Treatment

Double Bond Pharmaceutical International AB (publ) (“DBP”) and Vivo Biopharma LLC (“Vivo”), a wholly owned subsidiary of Sauvie Inc. (“Sauvie”) today announced that they have entered into an asset purchase, collaboration and transition agreements for DBP’s SI-053 development product and related assets. SI-053 is a locally acting formulation of temozolomide for the treatment of glioblastoma and it received Orphan Drug Designation from the European Medicines Agency in 2016.  Recently, SI-053 received both Competent Authority and Ethics Committee approvals to initiate a Phase 1 clinical trial

Nordea Bank Abp: Repurchase of own shares on 15.09.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares15.09.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 15.09.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |41,638 |10.28 |428,080.28

Could 100 Bitcoin BSC Make You a Millionaire? Here's Why BTCBSC Crypto Might Be The Next Coin to Explode

If you had bought $100 of Bitcoin in 2011, it would have been worth $3m when BTC was trading at $30,000 earlier this year – could Bitcoin BSC  repeat that feat?[Bitcoin BSC raises $2m - selling out fast] Crypto investors certainly think so, which explains why the ‘Bitcoin on BNB Smart Chain’ staking crypto asset has raised more than $2 million  in less than two weeks as its presale races toward the finish line of $3.96 million. Currently priced at just $0.99 in presale – roughly the price

DNB Bank ASA – status of share buy-back programme after week 37 2023

On 17 July 2023, DNB Bank ASA (“DNB”) announced that the company has decided to initiate a share buy-back programme comprising up to 1.5 percent of the company’s own shares, which represents a total of 23,139,197 shares.  Up to 15,271,870 shares will be bought back on trading venues by 18 October 2023, and a proposal will be made at the Annual General Meeting in 2024 to cancel the shares. At the same meeting it will also be proposed to redeem the remaining shares – up to 7,867,327 shares – from the Norwegian Government, represented by the Ministry of Trade, Industry and Fisheries (“NFD”),

Transaction in Own Shares

FIDELITY CHINA SPECIAL SITUATIONS PLC TRANSACTION IN OWN SHARES The Board of Fidelity China Special Situations Plc ("the Company") announces that on 15 September 2023 the Company bought 231,351 of its own shares for cancellation at a price of 211.187 pence per share.  The Company's issued ordinary share capital is 563,994,324 shares of which 85,629,548 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is 478,364,776. The above figure (478,364,776) may be used by shareholders as the denominator for the

Strictly Money Limited an emerging UK WealthTech company announces Stephen Ashurst and Will Povey as Joint-CEOs.

LONDON, 7 September 2023.   Strictly Money Limited an emerging UK WealthTech company announces Stephen Ashurst and Will Povey as Joint-CEOs.  Strictly Money champions this shift in leadership structure to foster a creative leadership style that promotes an agile and entrepreneurial organisation.   Stephen Ashurst and Will Povey share a united vision for Strictly Money. They will divide leadership based on their respective skillsets.  Stephan Ashurst joined the Strictly Money project from 2015 to lead its innovation and R&D projects.   Stephen is a professional business software

Bittium Corporation: SHARE REPURCHASE 15.9.2023

Bittium Corporation  ANNOUNCEMENT  15.9.2023 Bittium Corporation: SHARE REPURCHASE 15.9.2023 In the Helsinki Stock Exchange Trade date           15.9.2023Bourse trade         BuyShare                  BITTIAmount             2 200 SharesAverage price/ share    4,0300 EURTotal cost            8 866,00 EUR Bittium Corporation now holds a total of 184 429 sharesincluding the shares repurchased on 15.9.2023 On behalf of Bittium Corporation Nordea Bank Oyj

Christian Fladeland Appointed Deputy CEO

Heimstaden’s Chief Investment Officer, Christian Fladeland, will also serve as Deputy CEO, effective immediately.Since joining Heimstaden in January 2019, Christian has played a vital role in the company's senior executive management, making his appointment as Deputy CEO a natural progression due to his significant contributions to the company's positive development. In addition to overseeing the company's investment teams, Christian also leads the Corporate Finance Team.   Prior to joining Heimstaden, Christian held Partner positions at Colliers International and Sadolin & Albæk. He

Inside Information, Profit Warning: Bittium Corporation Lowers Its Financial Outlook for 2023

Bittium CorporationInside information Inside Information, Profit Warning: Bittium Corporation Lowers Its Financial Outlook for 2023 Bittium Corporation, Stock Exchange Release, September 15, 2023, at 6:05 pm (CEST+1) Bittium Corporation lowers its financial outlook for the year 2023. The company expects the net sales in 2023 to be at the same level or lower than in the previous year (EUR 82.5 million in 2022), and the operating result to be lower than in the previous year (EUR 0.3 million in 2022). Cash flow in 2023 is expected to be negative. The main reason for the decrease

Resolutions from the EGM of Elos Medtech AB (publ)

Elos Medtech AB (publ) (“Elos Medtech” or the “Company”) held an extraordinary general meeting on Friday 15 September 2023 in Gothenburg. Amendment of the articles of association The general meeting resolved, in accordance with the board of directors’ proposal, to: 1. increase the limits for the minimum and maximum share capital so that the share capital in the Company shall be not less than SEK 176,487,500 and not more than SEK 705,950,000; 2. increase the limits for the minimum and maximum number of shares, so that the number of shares in the Company shall be not less than 28,

Aker ASA: Mandatory Notification of Trade

Sofie Valdersnes, employee elected board member in Aker ASA and employee in Aker BP ASA, has today sold 540 shares in Aker BP ASA at a price of NOK 309 per share. Following the transaction, Sofie Valdersnes owns a total of 1,027 shares in Aker BP ASA and 0 shares in Aker ASA. Please see notification form attached. -ENDS- For more information, please contact: Media contactAtle Kigen, Head of Media Relations and Public Affairs Aker ASATel: +47 90 78 48 78E-mail: atle.kigen@akerasa.com Investor contactFredrik Berge, Head of Investor Relations Aker ASATel: +47 45 03 20

Installation growth July and Aug

CEO Babak Esfahani comments As we’ve received many questions regarding the installation pace, we would like to provide information on the installation growth for July and August. July: 15% growthAugust: 21% growth In the interim report for the second quarter, we communicated that the dip we observed in installations in April had recovered towards the end of the quarter. This trend continued during July and August. The luminaires do not constitute a significant part of this growth, as the products are only now starting to become available in larger volumes to customers. Please

#23-295 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Enhertu recommended in EU for HER2-mutant NSCLC

15 September 2023 Enhertu recommended for approval in the EU by CHMP forpatients with HER2-mutant advanced non-small cell lung cancerRecommendation based on DESTINY-Lung02 trial results which showed AstraZenecaand Daiichi Sankyo's Enhertu achieved strong and durable tumour responses inpreviously treated HER2-mutant disease Enhertu showed a confirmed objective response rate of 49% and median duration ofresponse of 16.8 months AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso

Metso Corporation’s stock exchange release on September 15, 2023, at 4:45 p.m. EESTMetso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the shareholding of BlackRock, Inc. On September 14, 2023, BlackRock's holding in Metso’s shares fell below the 5 percent threshold and amounted to 40,924,086 shares or 4.93 percent of total shares and votes. BlackRock's holding through financial instruments in Metso amounted to 1,669,146 shares, which corresponds to 0.20 percent of the total amount of Metso’s

Finnish investor Korkia to strengthen its position in Chile - partners with Ciudad Luz to kickstart new project development in Latin America

Finnish renewable energy investor Korkia and Chilean developer Ciudad Luz have established a joint venture to develop 500MW of solar, wind and hybrid projects in Chile over the course of four years. The projects will also include energy storage to help provide more reliability to the Chilean grid.The plans for the cooperation include solar, wind, hybrid and storage projectsin both utility-scale as well as PMGDs. The projects will be developed across Chile in locations suitable for the deployment of new NCRE projects and the technology will be carefully selected in order to contribute to

There are no items matching the current filter
There are no more items matching the current filter
Back to top